Article info

Download PDFPDF
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial

Authors

  1. Correspondence to Dominik Fischer, Universitätsklinikum Tübingen Universitäts-Augenklinik, Tubingen, Baden-Württemberg, Germany; dominik.fischer{at}uni-tuebingen.de
View Full Text

Citation

Reichel FF, Michalakis S, Wilhelm B, et al
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial

Publication history

  • Received February 19, 2021
  • Revised April 26, 2021
  • Accepted April 30, 2021
  • First published May 18, 2021.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.